Abstract
Autosomal recessive polycystic kidney disease (ARPKD) is mainly caused by variants in the PKHD1 gene, encoding fibrocystin (FC), a large transmembrane protein of incompletely understood cellular function. Here, we show that a C-terminal fragment of human FC can suppress a signalling module of the kinase SRC and signal transducer and activator of transcription 3 (STAT3). Consistently, we identified truncating genetic variants specifically affecting the cytoplasmic tail in ARPKD patients, found SRC and the cytoplasmic tail of fibrocystin in a joint dynamic protein complex and observed increased activation of both SRC and STAT3 in cyst-lining renal epithelial cells of ARPKD patients.
Author supplied keywords
Cite
CITATION STYLE
Dafinger, C., Mandel, A. M., Braun, A., Göbel, H., Burgmaier, K., Massella, L., … Liebau, M. C. (2020). The carboxy-terminus of the human ARPKD protein fibrocystin can control STAT3 signalling by regulating SRC-activation. Journal of Cellular and Molecular Medicine, 24(24), 14633–14638. https://doi.org/10.1111/jcmm.16014
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.